U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07418957) titled 'Efficacy and Safety of Vaginal Lactobacillus Dual Probiotic Capsules in Bacterial Vaginosis' on Feb. 04.
Brief Summary: Primary Objective: To confirm that the clinical cure rate of Vaginal Lactobacillus Dual Probiotic Capsules for bacterial vaginosis (BV) is superior to placebo at the 21-30 day post-treatment visit (Day 21 to Day 30).
Key Secondary Objective: To compare the clinical cure rate of Vaginal Lactobacillus Dual Probiotic Capsules versus placebo for BV at the 15-18 day post-treatment visit (Day 15 to Day 18).
Other Secondary Objectives: 1) To comprehensively assess the therapeutic efficacy of the study drug versus placeb...